Evolving landscape of treatments targeting the microenvironment of liver metastases in non-small cell lung cancer
{{output}}
Liver metastases (LMs) are common in lung cancer. Despite substantial advances in diagnosis and treatment, the survival rate of patients with LM remains low as the immune-suppressive microenvironment of the liver allows tumor cells to evade the immune system. ... ...
